Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
GLP-1s are not supposed to make you feel that you have low energy, Obici says
Jaclyn Bjorklund of Louisiana accuses Novo Nordisk, the maker of Ozempic, and Eli Lilly, which makes Mounjaro, another Type 2 diabetes treatment being used off-label for weight loss, of failing to warn or adequately warn of all the possible adverse side effects from using the medications, including the risk of gastroparesis, also known as paralyzed stomach. Bjorklund, 44, was diagnosed with Type 2 diabetes in 2017 and used Ozempic for more than one year, then stopped and switched to Mounjaro in July 2023 with both drugs prescribed by her doctors to control her blood sugar, according to court papers
Otros riesgos que los adultos mayores deberan considerar son la prdida de masa muscular y sea, la deshidratacin y los efectos secundarios digestivos
Watch your companion grow as you build consistency 5
